novel diagnostics & biomarkers for dlbcl and ctcl
Published 5 years ago • 394 plays • Length 8:01Download video MP4
Download video MP3
Similar videos
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
1:12
exciting advances in dlbcl: molecular characterization of subtypes & novel immunotherapeutic agents
-
3:04
applying molecular understanding of dlbcl to management strategies
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
1:28
novel ultra-sensitive mrd profiling tool predicts outcomes in dlbcl after frontline treatment
-
2:44
cns invasion in b-cell lymphoma: a novel diagnostic and prognostic tool
-
1:17
novel biomarkers and emerging therapies for sickle cell disease
-
1:35
the future directions of cll research: mechanisms of pathogenesis and novel biomarkers
-
18:16
identification of novel biomarkers for thyroid cancer through multi omics data analysis - by. cheena
-
22:35
haploid induction and breeding : by dr. william rooney
-
21:12
cdo - highly accurate & objective tests for melanocytic lesions of uncertain malignant potential
-
3:54
the use of tarc as a diagnostic biomarker in hodgkin lymphoma
-
2:33
identifying novel biomarkers and advancing the classification system in cll
-
1:57
biomarkers in lymphoma
-
3:59
enestnd: results from an exploratory biomarker analysis in cml
-
1:53
the current immunotherapeutic landscape for treatment of dlbcl
-
5:36
mcl0208: identification of novel genomic prognostic factors
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
2:05
novel therapies on the horizon for cutaneous t-cell lymphoma
-
2:12
using a novel machine learning model to analyze and predict the outcomes of patients with ndmm
-
2:14
how does biomarker testing impact dlbcl treatment options?
-
3:37
biomarker analysis of luspatercept versus epoetin alfa in lr-mds in the phase iii commands study